Literature DB >> 10780977

Effects of cannabinoid receptor agonists on neuronally-evoked contractions of urinary bladder tissues isolated from rat, mouse, pig, dog, monkey and human.

R S Martin1, L A Luong, N J Welsh, R M Eglen, G R Martin, S J MacLennan.   

Abstract

This study investigated the cannabinoid receptor, known to inhibit neuronally-evoked contractions of the mouse isolated urinary bladder, in bladder sections isolated from mouse, rat, dog, pig non-human primate or human. The CB(1)-like pharmacology of the cannabinoid receptor in mouse isolated bladder observed previously was confirmed in this study by the rank order of agonist potencies: CP 55940>/=WIN 55212-2>HU 210>JWH 015>anandamide, the high affinity of the CB(1) selective antagonist, SR 141716A (apparent pK(B) 8.7), and the low affinity of the CB(2) antagonist, SR 144528 (apparent pK(B)<6.5). In these studies, SR 141716A (10-100 nM) significantly potentiated electrically-evoked contractions in this tissue by an undetermined mechanism. A similar rank order of agonist potencies was determined in rat isolated bladder sections (CP 55, 940> or =WIN 55212-2>JWH 015). In this tissue, the maximal inhibitory effect of all agonists was lower than in the mouse bladder. Indeed, the effects of both HU 210 and anandamide were too modest to quantify potency accurately. In the rat isolated bladder, SR 141716A (30 nM) or SR 144528 (100 nM), reversed the inhibitory effect of WIN 55212-2 (apparent pK(B) = 8.4 and 8.0, respectively) or JWH 015 (apparent pK(B) = 8.2 and 7.4, respectively). These findings may demonstrate pharmacological differences between the rat and mouse orthologues of the CB(1) receptor. Alternatively, they may be attributed to a mixed population of CB(1) and CB(2) receptors that jointly influence neurogenic contraction of the rat bladder, but cannot be differentiated without more selective ligands. WIN 55212-2 had no effect on electrically-evoked contractions of bladder sections isolated from dog, pig, cynomolgus monkey and human. These findings suggest that the effect of cannabinoid agonists to inhibit neurogenic contraction of the mouse and rat bladder is not conserved across all mammalian species.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10780977      PMCID: PMC1571997          DOI: 10.1038/sj.bjp.0703229

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  22 in total

1.  Evaluation of binding in a transfected cell line expressing a peripheral cannabinoid receptor (CB2): identification of cannabinoid receptor subtype selective ligands.

Authors:  V M Showalter; D R Compton; B R Martin; M E Abood
Journal:  J Pharmacol Exp Ther       Date:  1996-09       Impact factor: 4.030

2.  Distinct cell groups in the lumbosacral cord of the cat project to different areas in the periaqueductal gray.

Authors:  V G Vanderhorst; L J Mouton; B F Blok; G Holstege
Journal:  J Comp Neurol       Date:  1996-12-16       Impact factor: 3.215

3.  Nabilone in the treatment of multiple sclerosis.

Authors:  C N Martyn; L S Illis; J Thom
Journal:  Lancet       Date:  1995-03-04       Impact factor: 79.321

Review 4.  Pharmacology of lower urinary tract smooth muscles and penile erectile tissues.

Authors:  K E Anderson
Journal:  Pharmacol Rev       Date:  1993-09       Impact factor: 25.468

5.  Characterization of two cloned human CB1 cannabinoid receptor isoforms.

Authors:  M Rinaldi-Carmona; B Calandra; D Shire; M Bouaboula; D Oustric; F Barth; P Casellas; P Ferrara; G Le Fur
Journal:  J Pharmacol Exp Ther       Date:  1996-08       Impact factor: 4.030

6.  Evidence for the presence of cannabinoid CB1 receptors in mouse urinary bladder.

Authors:  R G Pertwee; S R Fernando
Journal:  Br J Pharmacol       Date:  1996-08       Impact factor: 8.739

7.  Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine.

Authors:  R G Pertwee; L A Stevenson; D B Elrick; R Mechoulam; A D Corbett
Journal:  Br J Pharmacol       Date:  1992-04       Impact factor: 8.739

8.  Aminoalkylindoles: actions on specific G-protein-linked receptors.

Authors:  M Pacheco; S R Childers; R Arnold; F Casiano; S J Ward
Journal:  J Pharmacol Exp Ther       Date:  1991-04       Impact factor: 4.030

9.  Investigation of brain sites mediating cannabinoid-induced antinociception in rats: evidence supporting periaqueductal gray involvement.

Authors:  A H Lichtman; S A Cook; B R Martin
Journal:  J Pharmacol Exp Ther       Date:  1996-02       Impact factor: 4.030

10.  Localization of cannabinoid receptors and nonsaturable high-density cannabinoid binding sites in peripheral tissues of the rat: implications for receptor-mediated immune modulation by cannabinoids.

Authors:  A B Lynn; M Herkenham
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030

View more
  22 in total

1.  Human urothelial cell lines as potential models for studying cannabinoid and excitatory receptor interactions in the urinary bladder.

Authors:  Evangelia Bakali; Ruth A Elliott; Anthony H Taylor; David G Lambert; Jonathon M Willets; Douglas G Tincello
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-03-21       Impact factor: 3.000

Review 2.  The endocannabinoid system - a target for the treatment of LUTS?

Authors:  Petter Hedlund; Christian Gratzke
Journal:  Nat Rev Urol       Date:  2016-07-05       Impact factor: 14.432

3.  Urothelial bladder afferent neurons in the rat are anatomically and neurochemically distinct from non-urothelial afferents.

Authors:  Buffie J Clodfelder-Miller; Hirosato Kanda; Jianguo G Gu; Judy R Creighton; Timothy J Ness; Jennifer J DeBerry
Journal:  Brain Res       Date:  2017-12-30       Impact factor: 3.252

4.  Pharmacological characterization of cannabinoid receptor activity in the rat-isolated ileum myenteric plexus-longitudinal muscle preparation.

Authors:  R Makwana; A Molleman; M E Parsons
Journal:  Br J Pharmacol       Date:  2010-03-05       Impact factor: 8.739

5.  Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus.

Authors:  Natalia Dmitrieva; Karen J Berkley
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

Review 6.  Cannabinoids and Tremor Induced by Motor-related Disorders: Friend or Foe?

Authors:  Shokouh Arjmand; Zohreh Vaziri; Mina Behzadi; Hassan Abbassian; Gary J Stephens; Mohammad Shabani
Journal:  Neurotherapeutics       Date:  2015-10       Impact factor: 7.620

7.  Functional role of cannabinoid receptors in urinary bladder.

Authors:  Pradeep Tyagi; Vikas Tyagi; Naoki Yoshimura; Michael Chancellor
Journal:  Indian J Urol       Date:  2010 Jan-Mar

8.  Cannabinoid receptor expression in the bladder is altered in detrusor overactivity.

Authors:  Evangelia Bakali; John McDonald; Ruth A Elliott; David G Lambert; Douglas G Tincello
Journal:  Int Urogynecol J       Date:  2015-07-30       Impact factor: 2.894

9.  [Respiratory failure due to delta-9-tetrahydrocannabinol in a tetraplegic patient].

Authors:  M Neuburger; M Schley; M Schmelz; G Schuepfer; C Konrad
Journal:  Schmerz       Date:  2006-11       Impact factor: 1.107

Review 10.  Purinergic signalling in the urinary tract in health and disease.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.